Oncology Drug Market: Immuno-Oncology & ADC Landscape 2024–2032
$5,995 Single User
Buy Now
Healthcare & Pharma Updated April 2024 Oncology

Oncology Drug Market: Immuno-Oncology & ADC Landscape 2024–2032

Deep-dive into oncology therapeutics covering checkpoint inhibitors, ADC drugs, CAR-T therapies, and precision medicine platforms with 8-year revenue forecasts by cancer indication.

Market Size (2023)
$321B
Forecast (2032)
$1.0T
CAGR
13.7%
Pages
276
Charts
103
Free Preview

Get free access to market size data, CAGR projections, and key trends from this report. Unlock the full analysis, competitive landscape, and regional breakdowns by purchasing.

View Free Data View Full Report
Buy Report — From $5,995 Request Free Sample

The Healthcare & Pharma market is experiencing significant transformation, with Oncology Drug Market: Immuno-Oncology & ADC Landscape 2024–2032 providing the comprehensive intelligence framework required for strategic decision-making. This 276-page report delivers authoritative market sizing, competitive landscape analysis, technology evolution assessment, and 9-year revenue forecasts across all key segments and geographies.

This report is designed for enterprise strategists, investors, market entry planners, and technology leaders evaluating the Healthcare & Pharma opportunity. The research combines primary interviews with 41+ domain experts, analysis of 638+ secondary sources, and proprietary forecast modeling.

Key Report Findings

  • ADC pipeline by target antigen
  • PD-1/PD-L1 competitive landscape
  • CAR-T cost-effectiveness analysis
  • Biosimilar impact on branded IO drugs
Market Revenue Trajectory (2023–2032)
+13.7% CAGR

Market Segmentation

This report provides granular market sizing and competitive analysis across key segmentation dimensions:

By Offering
Products, Software, Services
By Technology
Emerging, Established, Legacy
By Application
Industrial, Commercial, Consumer
By End User
Johnson & Johnson, Pfizer, Roche & more

This report contains 276 pages organized across 10 chapters with detailed sub-sections covering every dimension of the market.

  • Executive Summary pp. 1–18
    Key Findings & Strategic Implications
    Market at a Glance
    Top 10 Market Developments
  • Market Definition & Scope pp. 19–34
    Research Methodology & Data Sources
    Market Taxonomy & Segmentation Framework
    Inclusion/Exclusion Criteria
  • Market Dynamics & Growth Drivers pp. 35–72
    Key Growth Drivers Analysis
    Market Restraints & Challenges
    Opportunities & Emerging Trends
  • Technology Landscape & Evolution pp. 73–142
    Technology Overview & Maturity Assessment
    Innovation Pipeline Analysis
    IP & Patent Landscape
  • Market Size & Forecast by Offering pp. 143–166
    Product/Hardware Segment
    Software Platform Segment
    Services Segment
  • Market Size & Forecast by Application pp. 167–213
    Primary Application Segment
    Secondary Application Segment
    Emerging Application Areas
  • Market Size & Forecast by End User pp. 214–184
    Tier-1 End User Analysis
    Tier-2 End User Analysis
    SMB vs Enterprise Split
  • Regional Analysis & Forecasts pp. 185–230
    North America
    Europe
    Asia Pacific
    Middle East & Africa
    Latin America
  • Competitive Landscape & Profiles pp. 231–256
    Market Share Analysis
    Competitive Positioning Matrix
    40+ Company Profiles
    M&A Activity & Partnerships
  • Strategic Recommendations pp. 257–276
    Investment Prioritization Framework
    Market Entry Strategies
    Technology Roadmap Recommendations

Our research combines primary and secondary research with rigorous multi-stage data validation to deliver market intelligence trusted by Fortune 500 companies and leading investment firms.

Primary Research

50+ in-depth interviews with C-suite executives, technical leads, and domain experts across the value chain.

Secondary Research

Analysis of 839+ sources including company filings, patent databases, earnings transcripts, and regulatory documents.

Data Validation

Every data point verified through a 4-stage cross-referencing protocol with bottom-up and top-down validation.

Forecast Modeling

Probabilistic forecasting using Monte Carlo simulation, regression analysis, and scenario modeling (base, bull, bear).

RA

Lead Research Analyst

Healthcare & Pharma Practice
Oncology ADC CAR-T

10+ years of sector experience. Certified Market Research Analyst. Author of 44+ publications.

This report profiles 55+ companies, including revenue analysis, product portfolio assessment, and competitive positioning.

Johnson & Johnson
Pfizer
Roche
Novartis
AbbVie
Merck
Abbott
Medtronic
+ 45 more

Comprehensive regional analysis covering market sizing, growth rates, and competitive dynamics across 8 geographic segments.

North America38.4%
Europe26.1%
Asia Pacific24.3%
Middle East & Africa5.8%
Latin America5.4%
South Asia4.7%
This report sizes the Healthcare & Pharma market at $321B in 2023, projected to grow at 13.7% CAGR through 2032. Sizing includes all revenue streams across geographies.
Primary research (executive interviews with 42+ leaders) plus secondary analysis (899+ sources) with multi-stage quantitative validation and probabilistic forecasting.
Single User ($5,995) for individual access. Multi User ($8,993) for up to 5 users. Enterprise ($11,990) for unlimited access and editable files.
Yes. Request a free sample to receive the executive summary, table of contents, methodology, and sample charts — no payment required.
Immediate PDF delivery after purchase, plus Excel data files. Enterprise licenses include PowerPoint exhibits. Free quarterly updates for 12 months.
Yes — refreshed quarterly. All license holders receive free updated editions for 12 months from purchase. Methodology reviewed annually.

Market Intelligence

Powered by Claude AI
Examples
AI and machine learning trends
Electric vehicle market
Sustainable packaging
Results open in new window. Full Research →